Zaklady FarmaFarmaceutyczne Polpharma

Company snapshot

Zaklady FarmaFarmaceutyczne Polpharma is a pharma organization headquartered in EU. Primary therapeutic focus areas include infections, Not applicable (submitted trial is a BE study in healthy participants), infection. NovaPharmaNews links 6 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 1 (6).

• 6 active pipeline program(s) linked via ClinicalTrials.gov.
• 6 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Zaklady FarmaFarmaceutyczne Polpharma. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Zaklady FarmaFarmaceutyczne Polpharma.

1. Jun 8, 2026 Clinical update

   A single-dose for infection — Phase 1

2. Jun 8, 2026 Clinical update

   A single-dose for infections — Phase 1

3. Jun 8, 2026 Clinical update

   01-DAP-BIO-24 — Phase 1

4. Jun 8, 2026 Clinical update

   01-AMO-CLA-BIO-25 — Phase 1

5. Jun 8, 2026 Clinical update

   Pharmacokinetic study of colistimethate sodium — Phase 1

View all clinical trial activity →

• What is Zaklady FarmaFarmaceutyczne Polpharma?

  Zaklady FarmaFarmaceutyczne Polpharma is a pharma organization headquartered in EU. Primary therapeutic focus areas include infections, Not applicable (submitted trial is a BE study in healthy participants), infection. NovaPharmaNews links 6 clinical program(s), 0 drug profile(s)

• Is Zaklady FarmaFarmaceutyczne Polpharma publicly traded?

  Zaklady FarmaFarmaceutyczne Polpharma appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Zaklady FarmaFarmaceutyczne Polpharma develop or market?

  We link 15 drug profile(s) where Zaklady FarmaFarmaceutyczne Polpharma is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/zaklady-farmafarmaceutyczne-polpharma-s-aceutyczne-polpharma-s-a#company-drugs.

• What are the latest developments for Zaklady FarmaFarmaceutyczne Polpharma?

  In the last 12 months our linked public records show 6 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Zaklady FarmaFarmaceutyczne Polpharma focus on?

  Zaklady FarmaFarmaceutyczne Polpharma focuses on infections, Not applicable (submitted trial is a BE study in healthy participants), infection based on our analysis of their pipeline programs and drug development activities.